Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Triple-Hormone-Receptor Agonist Retatrutide for Obesity (PubMed record, Jastreboff et al.)
Metabolic profiling, loss-of-function approaches, and pharmacologic activation studies demonstrated that NRF2 is both necessary and sufficient to restrain ILC2 effector function
Identity fields include CAS 2381089-83-2
The growing global prevalence of type 2 diabetes and obesity has significantly increased demand for GLP-1 receptor agonists such as semaglutide, liraglutide, and tirzepatide, which are known for their ability to manage blood glucose levels, support weight loss, and improve cardiovascular outcomes
US$ 22.14
US$ 26.11
US$ 22.19
US$ 25.78
US$ 25.41
US$ 25.27
US$ 27.23
US$ 28.12
![MOUNJARO, MOUNJARO Kwikpen 10mg [PRESCRIPTION REQUIRED] Available in Click & Collect](https://medias.watsons.com.ph/publishing/50058411%20MOUNJARO%2010mg%20%28BOX%20N%20PEN%29%20020426-BFHggWHL-zoom.png?version=1776229668)
